Towards the treatment of saphenous vein bypass graft failure - A perspective of the Bristol Heart Institute

Biorheology

Volumn 39, Issue 3-4, 2002, Pages 491-499

  Angelini, Gianni D ^a   Jeremy, Jamie Y ^a  

^a UNIVERSITY OF BRISTOL   (United Kingdom)

Author keywords

Treatment; Vein graft failure

Indexed keywords

RECOMBINANT DNA; THAPSIGARGIN;

ATHEROGENESIS; ATHEROSCLEROSIS; BYPASS SURGERY; CONFERENCE PAPER; CORONARY ARTERY BYPASS GRAFT; CORONARY ARTERY OBSTRUCTION; CORONARY CARE UNIT; GENE THERAPY; GENE TRANSFER; GRAFT FAILURE; HUMAN; INTIMA; MANAGEMENT; NONHUMAN; PHARMACOLOGICAL BLOCKING; RETROSPECTIVE STUDY; SAPHENOUS VEIN GRAFT; STENT; SURGICAL APPROACH; TREATMENT OUTCOME; TYPES OF STUDY; VEIN BYPASS; VEIN GRAFT;

ANIMALS; CALCIUM-TRANSPORTING ATPASES; CORONARY ARTERY BYPASS; CORONARY STENOSIS; ENZYME INHIBITORS; GENE THERAPY; HUMANS; HYPERPLASIA; MODELS, ANIMAL; MUSCLE, SMOOTH, VASCULAR; SAPHENOUS VEIN; SWINE; THAPSIGARGIN; TRANSPLANTATION, AUTOLOGOUS; TREATMENT FAILURE; TUNICA INTIMA;

EID: 0036373872     PISSN: 0006355X     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Conference Paper

References (52)

1. External stenting reduces early medial and neointimal thickening in a pig model of arteriovenous bypass grafting
2. Gene therapy for restenosis
3. Prevention of vein graft failure: Potential applications for gene therapy
4. Gene therapy for vein grafting: Tissue inhibitor of metalloproteinase-3 (TIMP-3) inhibits neointima formation in vitro and in vivo in part by promotion of apoptosis
5. Time-dependent inhibition of intracellular calcium mobilisation by low concentrations of thapsigagrin in human vascular smooth muscle cells
6. Progression of atherosclerosis in coronary arteries and bypass grafts: Ten years later
7. The biology of saphenous vein graft occlusion: Etiology and strategies for prevention
8. Effect of external stents on neointima formation in porcine vein grafts implanted by end-to-side anastomosis
9. A receptor antagonist, BSF 302146, is a potent inhibitor of porcine vein graft thickening, in vivo
10. Atherosclerosis and late closure of aortocoronary saphenous vein grafts: Sequential angiographic studies 2 weeks, 1 year, 5 to 7 years and 10 to 12 years after surgery
11. The relation of risk factors to the development of atherosclerosis in saphenous-vein bypass grafts and the progression of disease in the native circulation. A study 10 years after aortocoronary bypass surgery
12. Geometry of externally stented and unstented pig common carotid artery bypass grafts
13. Adenovirus-mediated gene transfer of soluble vascular cell adhesion molecules to porcine interposition vein grafts
14. Effect of angioplasty and grafting on porcine vascular nerves: A potential neurotropic role for endothelin-1
15. Distribution of endothelin-1 (ET) receptors (ET(A) and ET(B)) and immunoreactive ET-1 in porcine saphenous vein-carotid artery interposition grafts
16. Endothelin 1 and endothelin receptors in porcine saphenous vein-carotid artery grafts
17. Neural reorganisation in porcine vein grafts: A potential role for endothelin-1
18. Does external stenting reduce porcein vein graft occlusion via an action on vascular nerves?
19. Pathobiology of intimal hyperplasia: A review
20. Perspectives of arterial gene therapy for the prevention of restenosis
21. Thapsigargin inhibits vascular smooth muscle cell migration and intracellular calcium mobilisation
22. Short term exposure to thapsigargin inhibits neointima formation in human saphenous vein
23. Gene transfer of tissue inhibitor of metalloproteinase-2 inhibits metalloproteinase activity and neointima formation in human saphenous veins
24. Adenovirus-mediated gene transfer of human TIMP-1 gene inhibits smooth muscle cell migration and neointimal formation in human saphenous vein
25. The influence of external stent material on early neointimal formation and medial wall thickening in a model of saphenous vein bypass grafting
26. The natural history of saphenous vein grafts
27. Efficient and selective adenovirus-mediated gene transfer into vascular neointimal
28. Inhibition of cellular ras prevents smooth muscle cell proliferation after vascular injury in vivo
29. Coronary artery bypass surgery: Current practice in the United Kingdom
30. The influence of external stent size on early medial and neointimal thickening in a pig model of saphenous vein bypass grafting
31. Pathophysiology and treatment of vein graft failure
32. Eicosanoids, fatty acids and restenosis following balloon angioplasty and vein graft surgery
33. Nitric oxide synthase and cyclic nucleotide formation by porcine venous-arterial grafts
34. Platelets and saphenous vein graft failure
35. Short-term exposure to thapsigargin inhibits neointima formation in porcine vein grafts
36. Nitric oxide and vascular smooth muscle cell proliferation
37. Adenovirus-mediated transfer of the smooth muscle calponin gene inhibits proliferation of smooth muscle cells and fibroblasts
38. High efficiency gene transfer to autologous rabbit jugular vein grafts using adenovirus transferrin/polylysine DNA complexes
39. Long term (5-12 years) serial studies of internal mammary artery and saphenous vein coronary bypass grafts
40. Coronary bypass grafting economics, including rehabilitation
41. Experimental models of accelerated atherosclerosis syndromes
42. Towards a solution for vein graft failure
43. External stenting reduces long-term medial and neointimal thickening and platelet derived growth factor expression in a pig model of arteriovenous bypass grafting
44. Myointimal hyperplasia
45. Gene therapy for vascular smooth muscle cell proliferation after arterial injury
46. Gene transfer into specific vascular cells
47. 3H]-thymidine incorporation by cultured human vascular smooth muscle cells
48. Prevention of graft coronary arteriosclerosis by antisense cdk2 kinase oligonucleotide
49. Effects of external stenting on wall thickening in arteriovenous bypass grafts
50. Nitrated aspirin (NCX4016) inhibits neointima formation in porcine vein grafts
51. Adenoviruses as gene-delivery vehicles
52. Advances in adenoviral vectors: From genetic engineering to their biology